Stone House Investment Management »

Stoke Therapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 500 23.50
2025-06-30 $5.7k 500 11.35
2025-03-31 $3.3k 500 6.65
2024-09-30 $6.1k 500 12.29
2024-03-31 $6.8k 500 13.50

More positions owned by Stone House Investment Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Procter & Gamble Company (PG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 100 Etf (OEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Blackrock Etf Trust Ishares Us Thema (THRO)
Blackrock Etf Trust Ishares A I Inno (BAI)

View all positions for Stone House Investment Management

Top funds holding Stoke Therapeutics

FMR
BlackRock
Lynx1 Capital Management
Rtw Investments
Baker Bros. Advisors
Redmile Group
Morgan Stanley
Toronto-Dominion Bank
Vanguard Group
Skorpios Trust
Siren
BVF
State Street Corporation
Polar Capital Holdings
Point72 Asset Management

View all funds holding Stoke Therapeutics